M&T Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-16,979
| Closed | -$369K | – | 1836 |
|
|
2026
Q1 | $369K | Sell |
16,979
-5,286
| -24% | -$102K | ﹤0.01% | 1261 |
|
|
2025
Q4 | $480K | Buy |
+22,265
| New | +$469K | ﹤0.01% | 1146 |
|
|
2025
Q2 | – | Sell |
-3,562
| Closed | -$227K | – | 1619 |
|
|
2025
Q1 | $227K | Sell |
3,562
-862
| -19% | -$90.7K | ﹤0.01% | 1369 |
|
|
2024
Q4 | $538K | Sell |
4,424
-38
| -0.9% | -$4.66K | ﹤0.01% | 1137 |
|
|
2024
Q3 | $558K | Buy |
4,462
+349
| +8% | +$48.2K | ﹤0.01% | 1126 |
|
|
2024
Q2 | $650K | Sell |
4,113
-147
| -3% | -$18.9K | ﹤0.01% | 1015 |
|
|
2024
Q1 | $551K | Buy |
4,260
+683
| +19% | +$83.7K | ﹤0.01% | 1109 |
|
|
2023
Q4 | $345K | Sell |
3,577
-5
| -0.1% | -$480 | ﹤0.01% | 1256 |
|
|
2023
Q3 | $435K | Buy |
3,582
+411
| +13% | +$46.5K | ﹤0.01% | 1142 |
|
|
2023
Q2 | $363K | Buy |
3,171
+208
| +7% | +$26.8K | ﹤0.01% | 1242 |
|
|
2023
Q1 | $409K | Sell |
2,963
-3,777
| -56% | -$490K | ﹤0.01% | 1182 |
|
|
2022
Q4 | $873K | Sell |
6,740
-5
| -0.1% | -$579 | ﹤0.01% | 903 |
|
|
2022
Q3 | $747K | Buy |
6,745
+8
| +0.1% | +$806 | ﹤0.01% | 927 |
|
|
2022
Q2 | $505K | Buy |
6,737
+183
| +3% | +$13.5K | ﹤0.01% | 1003 |
|
|
2022
Q1 | $512K | Sell |
6,554
-412
| -6% | -$31.6K | ﹤0.01% | 980 |
|
|
2021
Q4 | $627K | Buy |
6,966
+140
| +2% | +$12K | ﹤0.01% | 926 |
|
|
2021
Q3 | $631K | Buy |
6,826
+146
| +2% | +$11.2K | ﹤0.01% | 908 |
|
|
2021
Q2 | $519K | Buy |
6,680
+607
| +10% | +$46K | ﹤0.01% | 1022 |
|
|
2021
Q1 | $453K | Sell |
6,073
-329
| -5% | -$30.4K | ﹤0.01% | 1047 |
|
|
2020
Q4 | $1.09M | Sell |
6,402
-916
| -13% | -$136K | ﹤0.01% | 737 |
|
|
2020
Q3 | $1.03M | Buy |
7,318
+4,554
| +165% | +$692K | 0.01% | 693 |
|
|
2020
Q2 | $443K | Sell |
2,764
-99
| -3% | -$13.5K | ﹤0.01% | 992 |
|
|
2020
Q1 | $279K | Sell |
2,863
-58
| -2% | -$6.63K | ﹤0.01% | 1161 |
|
|
2019
Q4 | $377K | Buy |
2,921
+88
| +3% | +$8.88K | ﹤0.01% | 972 |
|
|
2019
Q3 | $213K | Buy |
2,833
+717
| +34% | +$84.7K | ﹤0.01% | 1388 |
|
|
2019
Q2 | $321K | Sell |
2,116
-1,940
| -48% | -$236K | ﹤0.01% | 1187 |
|
|
2019
Q1 | $484K | Buy |
4,056
+1,077
| +36% | +$138K | ﹤0.01% | 981 |
|
|
2018
Q4 | $325K | Buy |
2,979
+114
| +4% | +$14.3K | ﹤0.01% | 1084 |
|
|
2018
Q3 | $464K | Buy |
+2,865
| New | +$392K | ﹤0.01% | 1029 |
|
|
2016
Q1 | – | Sell |
-5,963
| Closed | -$230K | – | 1800 |
|
|
2015
Q4 | $230K | Sell |
5,963
-1,630
| -21% | -$52.9K | ﹤0.01% | 1440 |
|
|
2015
Q3 | $244K | Buy |
+7,593
| New | +$258K | ﹤0.01% | 1422 |
|
|
2014
Q4 | – | Sell |
-10,500
| Closed | -$221K | – | 2232 |
|
|
2014
Q3 | $221K | Buy |
+10,500
| New | +$237K | ﹤0.01% | 1818 |
|
Other funds holding SRPT
EAM
M&T Bank's SRPT Position: Q2 2026 in Review
M&T Bank sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 16,979 shares — an estimated $369K sold.
M&T Bank first reported a position in SRPT in Q3 2014 and held it in 32 quarters. The position peaked at $1.09M in Q4 2020. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- M&T Bank reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- M&T Bank sold 16,979 Sarepta Therapeutics shares in Q2 2026, an estimated $369K.
- M&T Bank first reported a position in Sarepta Therapeutics in Q3 2014 and held it in 32 quarters.
- M&T Bank's Sarepta Therapeutics position peaked at $1.09M in Q4 2020.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.